- Home
- KFRC
KFRC
Kforce Inc.
as 02-21-2025 4:00pm EST
| Founded: | 1962 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $66.67 | AVG Volume (30 days): | 134.8K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.68 | EPS Growth: | -14.38 |
| 52 Week Low/High: | $48.21 - $74.79 | Next Earning Date: | 02-03-2025 |
| Revenue: | $1,405,308,000 | Revenue Growth: | -8.26% |
| Revenue Growth (this year): | 0.97% | Revenue Growth (next year): | 7.19% |
Stock Insider Trading Activity of Kforce Inc. (KFRC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| THOMAS ANDREW G | KFRC | Chief Experience Officer | Feb 10 '25 | Sell | $51.79 | 7,100 | $367,709.00 | 96,084 |
Latest Kforce Inc. News
KFRC Breaking Stock News: Dive into KFRC Ticker-Specific Updates for Smart Investing
Simply Wall St.
17 days ago
Kforce Full Year 2024 Earnings: In Line With Expectations
Thomson Reuters StreetEvents
18 days ago
Q4 2024 Kforce Inc Earnings Call
GuruFocus.com
18 days ago
Kforce Inc (KFRC) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Zacks
19 days ago
Kforce (KFRC) Meets Q4 Earnings Estimates
Associated Press Finance
19 days ago
Kforce: Q4 Earnings Snapshot
MT Newswires
19 days ago
Kforce Q4 Earnings, Revenue Decline; Q1 Outlook Issued; Quarterly Dividend Raised
Business Wire
19 days ago
Kforce Reports Fourth Quarter 2024 Revenue of $343.8 Million; Full Year 2024 EPS of $2.68 Per Share; Board of Directors Approves Increase in Quarterly Dividend for Sixth Consecutive Year
GuruFocus.com
22 days ago
Kforce Inc (KFRC) Q4 2024 Earnings Report Preview: What To Expect
Compare KFRC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KFRC Kforce Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.